查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1467891

消化性潰瘍藥物市場依產品類型（質子幫浦抑制劑、鉀競爭性酸阻斷劑、制酸劑、H2拮抗劑、抗生素、潰瘍保護劑）、潰瘍類型、配銷通路和地區2024-2032年

Peptic Ulcer Drugs Market by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker, Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球消化性潰瘍藥物市場規模達48億美元。消化性潰瘍的盛行率不斷增加，尤其是在老年族群中，以及消費者傾向於使用各種藥物而不是侵入性手術，這是推動市場發展的一些關鍵因素。

消化性潰瘍或十二指腸潰瘍是一種開放性潰瘍，逐漸發展並引發胃、小腸和下食道內壁的缺陷。它們通常是由於發炎、放射治療、頻繁口服和注射阿斯匹靈以及抗發炎藥物引起的。如果消化性潰瘍未及時治療，可能會引起中上身劇烈疼痛、體重減輕、內出血和嚴重失血，需要住院治療。目前，他們可以用多種藥物類型進行治療，包括質子幫浦抑制劑（PPI）、H2拮抗劑、抗生素、鉀競爭性酸阻斷劑（P-CAB）、制酸劑和潰瘍保護劑。這些藥物可以減輕身體疼痛，提供更多的癒合時間，最大限度地減少胃酸分泌，抵抗細菌感染，並保護胃免受消化液的侵害。因此，消化性潰瘍藥物被醫療保健從業人員廣泛用於治療胃炎、胃食道逆流（GERD）和十二指腸潰瘍。

消化性潰瘍藥物市場趨勢：

消化性潰瘍的盛行率不斷增加，特別是在老年族群中，是推動市場成長的關鍵因素之一。此外，不健康的生活習慣和胃癌發病率的上升，導致越來越多的人患有消化性潰瘍。再加上消費者對各種消化性潰瘍治療藥物而非侵入性手術的傾向不斷變化，這反過來又促進了市場的成長。與此一致的是，與外科手術相比，幾種類固醇抗發炎藥物具有微創性、更實惠，並且可以在確保減少失血的同時實現更快的恢復。此外，消化性潰瘍藥物的持續批准以及政府對製藥公司的藥物配方投資也支持了市場的成長。這進一步受到持續進行新藥形成臨床試驗以克服併發症和市面上現有藥物無效的影響。此外，消費者越來越意識到經濟高效的消化性潰瘍藥物的好處及其在多個分銷管道上的便利性，這有利於市場的成長。用於執行診斷和法醫操作的基於人工智慧（AI）的病理測試技術的出現也推動了市場的成長。其他因素，例如為提高產品功效而進行的廣泛研發（R＆D）活動以及增加用於開發治療消化性潰瘍的非處方（OTC）藥物的投資，正在對市場成長產生積極影響。

本報告回答的關鍵問題：

  • 迄今為止，全球消化性潰瘍藥物市場表現如何，未來幾年將如何表現？
  • 全球消化性潰瘍藥物市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的消化性潰瘍藥物市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 根據潰瘍類型市場的細分是什麼？
  • 基於配銷通路的市場區隔是什麼？
  • 全球消化性潰瘍藥物市場競爭格局如何？
  • 誰是全球消化性潰瘍藥物市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球消化性潰瘍藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 質子幫浦抑制劑
    • 市場走向
    • 市場預測
  • 鉀競爭性酸阻斷劑 (P-CAB)
    • 市場走向
    • 市場預測
  • 制酸劑
    • 市場走向
    • 市場預測
  • H2-拮抗劑
    • 市場走向
    • 市場預測
  • 抗生素
    • 市場走向
    • 市場預測
  • 潰瘍防護
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按潰瘍類型

  • 胃潰瘍
    • 市場走向
    • 市場預測
  • 十二指腸潰瘍
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Novitium Pharma LLC
    • Pfizer Inc.
    • PharmaKing Co. Ltd.
    • RedHill Biopharma Ltd
    • Viatris Inc.
    • Yuhan Corporation
    • Zydus Lifesciences Limited
Product Code: SR112024A6684

The global peptic ulcer drugs market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2032, exhibiting a growth rate (CAGR) of 2.65% during 2024-2032. The increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various medications over invasive surgeries represent some of the key factors driving the market.

Peptic ulcers, or duodenal ulcers, are open sore that gradually develops and triggers defects in the lining of the stomach, small intestine, and lower esophagus. They are usually caused due to inflammation, radiation therapy, frequent oral and injectable administration of aspirins, and anti-inflammatory drugs. If peptic ulcers are left untreated, they might initiate severe pain in the mid- or upper-body parts, weight loss, internal bleeding, and severe blood loss, which require hospitalization. Currently, they can be treated with various drug types, including proton pump inhibitors (PPI), H2 antagonists, antibiotics, potassium-competitive acid blockers (P-CAB), antacids, and ulcer protectives. These medications reduce body aches, provide more time to heal, minimize acid secretion, offer resistance against bacterial infections, and protect the stomach from digestive juices. As a result, peptic ulcer drugs are extensively utilized by healthcare practitioners for the treatment of gastritis, gastroesophageal reflux disease (GERD), and duodenal ulcers.

Peptic Ulcer Drugs Market Trends:

The increasing prevalence of peptic ulcers, especially amongst the geriatric population, represents one of the key factors driving the market growth. Moreover, unhealthy lifestyle habits and rising instances of stomach cancer, is resulting in the growing number of individuals suffering from peptic ulcers. This, along with the shifting consumer inclination towards various peptic ulcer-curing drugs over invasive surgeries, which, in turn, is contributing to the market growth. In line with this, as compared to surgical procedures, several steroidal anti-inflammatory medications are minimally invasive, more affordable, and enable faster recovery while ensuring reduced blood loss. Additionally, the ongoing approvals of peptic ulcer drugs and several government investments in pharmaceutical companies for the formulation of medications are supporting the market growth. This is further influenced by the continuous conduction of clinical trials for new drug formation to overcome complications and the ineffectiveness of present drugs in the market. Moreover, the increasing consumer awareness regarding the benefits of cost-effective peptic ulcer drugs and their easy availability across multiple distribution channels is favoring the market growth. The advent of artificial intelligence (AI)-based pathology testing technology to perform diagnostic and forensic operations is also propelling the market growth. Other factors, such as extensive research and development (R&D) activities to enhance product efficacy and the increasing investments in the development of the over the counter (OTC) medications for treating peptic ulcers, are positively impacting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global peptic ulcer drugs market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product type, ulcer type, and distribution channel.

Product Type Insights:

Proton Pump Inhibitors

Potassium-Competitive Acid Blocker (P-CAB)

Antacids

H2-Antagonists

Antibiotics

Ulcer protective

The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the product type. This includes proton pump inhibitors, potassium-competitive acid blocker (P-CAB), antacids, H2-antagonists, antibiotics, and ulcer protective. According to the report, antibiotics represented the largest segment.

Ulcer Type Insights:

Gastric Ulcer

Duodenal Ulcer

Others

A detailed breakup and analysis of the peptic ulcer drugs market based on the ulcer type has also been provided in the report. This includes gastric ulcer, duodenal ulcer, and others. According to the report, duodenal ulcer accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for peptic ulcer drugs. Some of the factors driving the North America peptic ulcer drugs market included the increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various peptic ulcer curing drugs over invasive surgeries and the fueling need for over-the-counter (OTC) medications in the healthcare sector.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global peptic ulcer drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novitium Pharma LLC, Pfizer Inc., PharmaKing Co. Ltd., RedHill Biopharma Ltd, Viatris Inc., Yuhan Corporation, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global peptic ulcer drugs market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global peptic ulcer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive peptic ulcer drug markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the ulcer type?
  • What is the breakup of the market based on the distribution channel?
  • What is the competitive structure of the global peptic ulcer drugs market?
  • Who are the key players/companies in the global peptic ulcer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peptic Ulcer Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Potassium-Competitive Acid Blocker (P-CAB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antacids
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 H2-Antagonists
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antibiotics
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Ulcer Protective
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Ulcer Type

  • 7.1 Gastric Ulcer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Duodenal Ulcer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Novitium Pharma LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PharmaKing Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 RedHill Biopharma Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Viatris Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Yuhan Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zydus Lifesciences Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Peptic Ulcer Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Peptic Ulcer Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Peptic Ulcer Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Peptic Ulcer Drugs Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Peptic Ulcer Drugs Market: Breakup by Ulcer Type (in %), 2023
  • Figure 6: Global: Peptic Ulcer Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Peptic Ulcer Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Peptic Ulcer Drugs (Antacids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Peptic Ulcer Drugs (Antacids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Peptic Ulcer Drugs (H2-Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Peptic Ulcer Drugs (H2-Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Peptic Ulcer Drugs (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Peptic Ulcer Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Peptic Ulcer Drugs (Ulcer Protective) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Peptic Ulcer Drugs (Ulcer Protective) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Peptic Ulcer Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Peptic Ulcer Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Peptic Ulcer Drugs Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Peptic Ulcer Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Peptic Ulcer Drugs Industry: Value Chain Analysis
  • Figure 83: Global: Peptic Ulcer Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peptic Ulcer Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Ulcer Type (in Million US$), 2024-2032
  • Table 4: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Peptic Ulcer Drugs Market: Competitive Structure
  • Table 7: Global: Peptic Ulcer Drugs Market: Key Players